Last reviewed · How we verify

NCT05314218

The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting

Completed Last updated 13 June 2023
What this trial tests

trial testing Electrophysiology catheters and cables in Cardiac Arrhythmia in 168 participants. Completed in 26 May 2023.

Timeline
23 May 2022
Primary endpoint
25 May 2023
26 May 2023

Quick facts

Lead sponsorAlcis
StatusCompleted
Study typeOBSERVATIONAL
Enrollment168
Start date23 May 2022
Primary completion25 May 2023
Estimated completion26 May 2023
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Alcis

Who can join

Adults 18 to 90, any sex, with Cardiac Arrhythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this multicentre study is to collect operative data on the related clinical functional outcomes and complications and of market approved Alcis electrophysiology catheters to demonstrate safety and performance of these devices in a real-world setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cardiac Arrhythmia

Currently open trials in the same condition.

Other Alcis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05314218.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing